Healthy women test skin blood flow drug in early study
NCT ID NCT04183283
First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 29 times
Summary
This early-stage study looked at how a single dose of the experimental drug LY3526318 changes blood flow in the skin of healthy women. Sixteen participants received the drug or a placebo, and their skin blood flow was measured after applying a cinnamon-like substance. The goal was simply to learn about the drug's effects, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg
Leuven, 3000, Belgium
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.